Severe Covid infection in kids linked to heart disease risks: Study
New Delhi: While children are largely thought to be less susceptible to Covid-19's serious effects on the lungs, a global study has indicated that in children suffering from severe infection with SARS-COV-2 virus, the health risks may go beyond the acute viral infection and can harm the heart.
Scientists from Harvard University (US) and Murdoch University (Australia) analysed blood samples from 147 children across different Covid.
Their study identified significant metabolic disruptions that affect how the body processes fats (triglycerides and cholesterol) critical to healthy heart structure.
"This research challenges the widespread assumption that children are largely unaffected by Covid-19 based on the relatively mild respiratory effects,' said lead researcher Professor Jeremy Nicholson, Director of The Australian National Phenome Centre.
Using nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry, the team measured 1,101 metabolites.
The findings, published in the Journal of Proteome Research, showed that children with Covid and related MIS-C (Multisystem Inflammatory Syndrome in Children) had major shifts in blood metabolic patterns, some of which include shifts in cardiovascular disease risk markers.
MIS-C affects multiple organ systems and may cause considerable cardiac damage, including myocardial and vascular changes.
The similarities were found between the molecular signatures of MIS-C and Covid in children, with the MIS-C patients being more severely affected.
"A minority of children experience a more severe immunologically driven form of the disease (MIS-C) that is associated with longer-term gastrointestinal effects and cardiovascular disease," said Nicholson.
Despite milder clinical respiratory symptoms, children's metabolic disturbances mirrored those seen in severe adult Covid patients, indicating a shared inflammatory response to SARS-CoV-2, suggesting potential long-term health impacts.
'We now need to do more research into the possible longer-term effects of Covid-19 in children' added Professor Julien Wist from the varsity.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
"Recorded 57 active COVID-19 cases as of today", says Sikkim Health Minister GT Dhungel
Gangtok: Sikkim Health Minister GT Dhungel said on Saturday that the state has 57 active Covid-19 cases . He added that the health department is fully prepared, with doctors, nurses, and medical staff on alert and hospitals equipped with beds, medicines, and necessary equipment. Speaking to the reporters, GT Dhungel said, "We have recorded 57 active cases as of today from across the state. The entire department is well-prepared, and all doctors, nurses, and technicians have been put on alert. The rooms have been equipped with adequate beds, medicines, and other necessary equipment." Meanwhile, health authorities in Rajasthan and Madhya Pradesh have reported a mild uptick in COVID-19 cases, though officials assert that the situation remains under control with no indication of widespread concern. In Rajasthan, Dr Ravi Prakash Sharma, Director of the Department of Medical, Health & Family Welfare, said that the state is currently seeing "30 to 35 new COVID-19 cases every day", with one death recorded so far. "We are seeing 30-35 cases of COVID every day in the state. We have sufficient stock of medicines," he said. Dr Sharma added that the deceased patient also suffered from tuberculosis and that the state has adequate supplies of medicines and is closely monitoring the situation. In Gwalior, Madhya Pradesh, authorities at Gajra Raja Medical College have reported multiple COVID-19 cases among medical staff, including junior doctors. Dr RKS Dhakad, the institution's dean, stated that 6 to 7 junior doctors have tested positive but reassured that all cases are mild and under observation. "Several tests have returned positive, including some junior doctors. The situation is not serious. Guidelines have already been issued," Dr Dhakad told reporters. According to the Ministry of Health and Family Welfare's official dashboard, as of June 13, India reported 7,131 active COVID-19 cases and 10,976 recoveries.
Time of India
3 hours ago
- Time of India
Hay fever vs. COVID-19: How to tell the difference
Spring's in the air… and so is pollen. But these days, a runny nose or sneezing fit doesn't just make you reach for tissues—it makes you wonder, 'Wait… is this hay fever, or did I catch something worse?' Welcome to the age of allergy anxiety. COVID-19 is still hanging around in waves, and hay fever (aka allergic rhinitis) shows up like clockwork each year, causing sniffles, itchy eyes, and sinus pressure that weirdly feel suspiciously like early COVID symptoms. So how do you actually tell the difference? Hay fever isn't caused by hay and it's not a fever. It's an allergic response to pollen, dust mites, mold, or pet dander. Your immune system overreacts to these harmless particles like they're invaders, leading to inflammation in your nose, throat, eyes, and sinuses. I t's super common especially from late March to September when pollen counts go wild. Depending on where you live, tree pollen starts first, followed by grass, and finally weed pollen in late summer. The early symptoms Let's say you wake up with a scratchy throat and a mild headache. Cue panic. Here's where it gets confusing—both hay fever and COVID-19 can cause: A runny or blocked nose Sneezing Sore throat Tiredness Headache Cough (especially from postnasal drip in hay fever) But the why and how long behind the symptoms often differ. COVID-19 symptoms COVID tends to sneak in like a full-body invader. Early on, you might feel "off"—chills, muscle aches, fatigue that hits like a truck. Fever is a common red flag. And loss of taste or smell? That's a signature COVID move, especially if it happens suddenly without a blocked nose. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 오스템 임플란트 받아가세요 임플란터 더 알아보기 Undo COVID symptoms usually come on quickly and worsen over 2–3 days. You might start with a sore throat or fatigue, and then by day 2 or 3, you've got a hacking cough, fever, or worse. Key clues it's probably COVID-19: sudden loss of taste or smell, fever or chills, body aches, shortness of breath, nausea or diarrhea. Symptoms appear abruptly and get worse over a few days Hay fever is usually more of a face attack You'll feel it in your eyes, nose, and throat—sometimes even in your ears. Itchy, watery eyes are a classic giveaway. And the congestion or sneezing fits often follow a very predictable pattern—worse in the morning, better after a shower, or triggered by walking past a blooming tree. Plus, if it happens every spring or always gets worse when you mow the lawn, there's your answer. Key clues it's probably hay fever are itchy or watery eyes, no fever at all, symptoms are seasonal or triggered by outdoors. It improves with antihistamines and the sneezing fits or nasal itching that don't turn into body aches The sneeze test Yes, both conditions can make you sneeze. But hay fever sneezes usually come in bunches—like rapid-fire explosions. COVID-related sneezing is much less common. If your sneezing is uncontrollable and paired with itchy eyes or ears, that leans heavily toward hay fever. Taste and smell If you suddenly lose your ability to taste your coffee or can't smell your shampoo, but your nose isn't even that blocked, that's a huge red flag for COVID-19. In hay fever, smell and taste can dull a bit—but mostly because your nose is stuffed, not because the virus is messing with your nervous system. How to be sure: Rapid tests and allergy meds If you're still in doubt, take a COVID-19 rapid antigen test. They're quick, and they're a good first step. Another trick? Try an over-the-counter antihistamine. If your symptoms improve in an hour or two, it's likely hay fever. COVID doesn't care about allergy meds. Can you have both at once? Sadly, yes Just to make life harder, you can have COVID-19 and hay fever at the same time. If your allergies are flaring and suddenly you feel exhausted, feverish, or short of breath, don't chalk it all up to pollen. Test yourself, stay cautious, and isolate if needed. If you're someone who deals with allergies every spring like clockwork, and your symptoms feel just like last year, it's probably hay fever. But if something feels off, especially with fatigue or fever, don't wait—test and stay safe. One step to a healthier you—join Times Health+ Yoga and feel the change
Time of India
3 hours ago
- Time of India
UAE scientists create paper test that diagnoses diseases in 10 mins, no lab needed!
UAE's 10-minute paper test can be quickly modified to detect COVID-19, malaria, dengue, chickenpox, and more/ Photo : Abu Dhabi Media Office A breakthrough in infectious disease testing is set to revolutionize the way healthcare is approached in low-resource and remote settings. A team of scientists at New York University Abu Dhabi (NYUAD) has unveiled a paper-based diagnostic tool, the Radially Compartmentalised Paper Chip (RCP-Chip), capable of detecting diseases in under 10 minutes. This innovation is a game-changer for fast, affordable, and portable disease screening without the need for complex lab equipment or trained personnel. Addressing the Global Need for Rapid Testing The RCP-Chip was conceived during the early days of the COVID-19 pandemic, when the world was grappling with a shortage of efficient testing methods, particularly in areas with limited resources. "Our goal was to create something fast, affordable, and easy to use, especially in areas where lab access is limited," said Mohammad A. Qasaimeh, Associate Professor of Mechanical Engineering and Bioengineering at NYUAD. Qasaimeh is the senior author of the study that led to the development of the RCP-Chip. The new tool offers a simple and rapid solution for detecting infectious diseases. "It uses a minimal number of reagents and requires only a small sample to run," Qasaimeh added, emphasizing the affordability and efficiency of the device. This paper-based diagnostic chip can be deployed easily in diverse settings, from remote villages to urban areas, and can significantly improve healthcare access. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Memperdagangkan CFD Emas dengan salah satu spread terendah? IC Markets Mendaftar Undo A Versatile Diagnostic Tool While the RCP-Chip was originally designed to detect COVID-19, its capabilities extend far beyond the novel coronavirus. According to Qasaimeh, the device is easily reconfigurable to diagnose other diseases such as chickenpox, dengue, malaria, and more. "With minor modifications, it can be adapted to diagnose a wide range of diseases or even test hormones and metabolites," Qasaimeh explained. This flexibility positions the RCP-Chip as a multi-purpose diagnostic tool that could be used in various medical fields, from general infectious disease testing to monitoring chronic health conditions. "What makes it truly impactful is its real-world potential," said Pavithra Sukumar, a Research Assistant at NYUAD and the co-first author of the study. Sukumar highlighted the tool's capacity to significantly improve outbreak responses, enabling faster isolation, treatment, and control. In situations where time is of the essence, such as in epidemic or pandemic scenarios, the rapid testing offered by the RCP-Chip can help curb the spread of diseases before they become uncontrollable. Simple, Cost-Effective, and Portable One of the standout features of the RCP-Chip is its portability. Unlike traditional diagnostic devices that require sophisticated lab setups, the chip can be operated with minimal resources. "It requires a heating stage at around 60 degrees Celsius, which can be easily achieved with common household devices like a hot plate or an oven," Qasaimeh explained. The simplicity of the design allows for easy transport and deployment, ensuring that healthcare workers in areas with limited infrastructure can use it effectively. Moreover, the RCP-Chip uses saliva samples instead of traditional swabs, making it even more convenient and comfortable for patients. "In a short amount of time, you can deploy it for use in almost any area," Qasaimeh said. This feature was a key motivation behind the development of the tool, aiming to reduce the time and cost typically associated with traditional diagnostic methods. From Concept to Commercialization The development of the RCP-Chip was not without its challenges. Due to pandemic-related lab access restrictions, the team faced delays during the initial stages of research. "In the initial phase, we focused on designing the chip and brainstorming the approaches," said Qasaimeh. It wasn't until restrictions were eased that the team was able to conduct in-depth testing of the device. "After initial curfews, gradually we were allowed access to labs, and that's when we deepened the research and began testing the device," he explained. Despite these challenges, the team successfully filed a patent for the device and launched a startup to commercialize it. Biotech companies have already expressed interest in the innovation. "We aim to find investors so that we can continue with the development stage of the device," Qasaimeh added. The focus now is on bringing the device to market and further developing its translational potential, ensuring that it can be adapted for various purposes in the healthcare sector. With the growing demand for affordable and effective diagnostic tools, the RCP-Chip is poised to play a pivotal role in global healthcare. Its low cost, speed, and versatility make it an ideal solution for resource-limited settings, providing a much-needed alternative to current testing methods.
